Irina Ziyatovna Bondarenko

Irina Ziyatovna Bondarenko

Auto-generated profile, based on publicly available information

Irina Ziyatovna Bondarenko

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2018 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
IDIvan Ivanovich Dedov
Ivan Ivanovich Dedov
GMGalina A. Mel'NIchenko
Galina A. Mel'NIchenko
MSMarina Shestakova
Marina Shestakova
ETEkaterina Troshina
Ekaterina Troshina
NMNatalya V. Mazurina
Natalya V. Mazurina
РИРоманцова Татьяна Ивановна
Романцова Татьяна Ивановна
The presented paper is a third revision of the clinical recommendations for the treatment of morbid obesity in adults. Morbid obesity is a condition with body mass index (BMI) 40 kg / m2 or a BMI 35 kg / m2 in the presence of serious complications associated with obesity. The recommendations provide data on the prevalence of obesity, its etiology and pathogenesis, as well as on associated complications. The necessary methods for laboratory and instrumental diagnosis of obesity are described in detail. In this revision of the recommendations, the staging of prescribing conservative and surgical methods for the treatment of obesity are determined. For the first time, a group of patients with obesity and type 2 diabetes mellitus is selected, in whom metabolic surgery allows a long-term improvement in the control of glycemia or remission of diabetes mellitus.

14 February 2021 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
IDI. I. Dedov
I. I. Dedov
MSMarina Shestakova
Marina Shestakova
GMG. A. Melnichenko
G. A. Melnichenko
NMN. V. Mazurina
N. V. Mazurina
EAE. N. Andreeva
E. N. Andreeva
МХМ. Б. Хамошина
М. Б. Хамошина
МЕЖДИСЦИПЛИНАРНЫЕ КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ «ЛЕЧЕНИЕ ОЖИРЕНИЯ И КОМОРБИДНЫХ ЗАБОЛЕВАНИЙ»

22 June 2020 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
ИДИван Иванович Дедов
Иван Иванович Дедов
MSMarina Shestakova
Marina Shestakova
AMAlexander Y. Mayorov
Alexander Y. Mayorov
MSMinara S. Shamkhalova
Minara S. Shamkhalova
OSOlga Yu. Sukhareva
Olga Yu. Sukhareva
ЮХЮрий Шавкатович Халимов
Юрий Шавкатович Халимов
Сахарный диабет 2 типа у взрослых

23 June 2019 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
VKViktor Y. Kalashnikov
Viktor Y. Kalashnikov
OVOlga K. Vikulova
Olga K. Vikulova
AZAnna Zheleznyakova
Anna Zheleznyakova
MIMikhail А. Isakov
Mikhail А. Isakov
IBIrina Z. Bondarenko
Irina Z. Bondarenko
IDIvan I. Dedov
Ivan I. Dedov
BACKGROUND: Cardiovascular diseases (CVD) are the main cause of death for patients with diabetes mellitus (DM). AIMS: To evaluate the CVD epidemiology: coronary heart disease (CHD), myocardial infarction (MI) and cerebrovascular diseases in adult patients with type 1 (T1DM) and type 2 (T2DM) diabetes, compare dynamics with data of implementation of the Federal Program Diabetes mellitus in 20072012 and over the online period 20132016. MATERIALS AND METHODS: The database of the Federal Diabetes register (81 regions at 12.2017). We estimated prevalence and incidence rates/10 thousand (th) adult DM patients over 18 years. RESULTS: The prevalence of CVD for the period 2007 2016 significant decreased in CHD for T1DM from 14,9% to 3,5%, for T2DM from 20,1% to 11,7%; MI for T1DM from 5,7% to 1,3%, for T2DM from 7,6% to 3,5%; cerebrovascular diseases for T1DM from 4,9% to 1,7%, for T2DM from 7,6% to 4,3%, respectively. In 20132016 positive trends continued: MI for T1DM 8,25,9/10th patients, for T2DM 19,214,7/10th patients, respectively; CVD for T1DM 11,310,5, for T2DM 29,425,4/10th patients, respectively. There was a large heterogeneity of the prevalence of CVD in the regions. MI varied in patients for T1DM from 319/10 th patients to absence, for T2DM from 800 to 7/10 th patients; the development of cerebrovascular diseases for T2DM from 900 to less than 100/10 th patients, which is largely due to differences in their registration. A small number of cases may be due to insufficient filling of the database, the facts of a huge number require further analysis. The average age of development of MI had increased: for T1DM 51,253 years, for T2DM 63,565 years, cerebrovascular diseases for T1DM 52,352.5 years, for T2DM 65,266,5, respectively. CONCLUSIONS: The prevalence of CVD significantly decreased in the Russian Federation compared to 20072012, as well as for the period 20132016: the prevalence of CHD and cerebrovascular diseases declined, the number of new cases of MI decreased, the average age and duration of DM before the development of CVD significantly increased. These data reflect the results of the program for improvement medical care and prevention measures for patients with diabetes.

10 August 2017 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
KPKirill A. Popov
Kirill A. Popov
ATAlla Y. Tokmakova
Alla Y. Tokmakova
IBIrina Z. Bondarenko
Irina Z. Bondarenko
Diabetic cardiovascular autonomic neuropathy (DCAN) is a diabetic complication characterised by early dissemination of sympathetic and parasympathetic, small-fibre neuronal degeneration. DCAN is the most dangerous and insidious complication that influences the clinical course and mortality rate of diabetes; however, it is often underestimated and not recognised by practitioners. Medical history and a physical examination are not sufficient for diagnosing DCAN. Laboratory diagnosis and the instrumental methods used to evaluate DCAN are time-consuming and not always available. Early detection of DCAN in diabetic patients is important for the early implementation of therapy. Today, there is no uniform diagnostic algorithm for DCAN in patients with various disorders of carbohydrate metabolism. This is due to the insufficient number of clinical trials and limitations of current protocols. This review presents an overview of the clinical and experimental studies of DCAN. The epidemiology, clinical manifestations, risk factors and underlying pathogenesis of DCAN are considered. The advantages and disadvantages of conventional and new diagnostic methods are discussed.

22 November 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OVOksana I. Vengrzhinovskaya
Oksana I. Vengrzhinovskaya
IBIrina Z. Bondarenko
Irina Z. Bondarenko
OSOlga A. Shatskaya
Olga A. Shatskaya
LNLarisa V. Nikankina
Larisa V. Nikankina
VKViktor Y. Kalashnikov
Viktor Y. Kalashnikov
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Early screening of complications of diabetes mellitus (DM) is one of the priorities for public health. Most patients with type 1 diabetes mellitus (T1DM) are patients of working age. New strategies for the primary prevention of cardiovascular disease (CVD) are needed to prevent their early disability. Aim. To assess the predictive value of adipokines in relation to a personalized approach to the need for an in-depth examination of young patients with T1DM. Materials and methods. The study included 98 patients without CVD: 70 patients with T1DM (mean age 26.48.1 years) and 28 patients without DM (mean age 279 years). All patients underwent a general clinical examination, the levels of adipokines were determined, ergospirometry, echocardiography, and bioimpedancemetry were performed. Results. Changes in the cardiorespiratory system in patients with T1DM were revealed, in comparison with persons without T1DM: anaerobic threshold was reached faster (p=0.001), maximum oxygen consumption was lower (p=0.048), metabolic equivalent was reduced (p=0.0001). Signs of myocardial remodeling were found in the T1DM group: there was an increase in the relative wall thickness (p=0.001), the posterior wall of the left ventricle (p=0.001), myocardial mass index (p=0.049), in comparison with persons without T1DM. Changes in the adipokines system were revealed: higher levels of resistin (p=0.002) and visfatin (p=0.001), lower level of adiponectin (p=0.040) in T1DM. A positive correlation was found between posterior wall of the left ventricle and visfatin (p=0.014) and a negative relationship between adiponectin and relative wall thickness (p=0.018) in T1DM. Conclusion. In T1DM, even at a young age, there are multifactorial changes in the heart, which can be detected even at the preclinical stage. The data obtained can be used to identify groups of patients at high risk of developing dangerous CVD in T1DM, which can form the basis for determining the timing of the start of preventive therapy.